Related Experiment Video
Updated: Feb 2, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity
Caroline Giessner1, Virginie Millet1, Konrad J Mostert2
1Aix Marseille Univ, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre d'Immunologie de Marseille Luminy, Marseille, France.
Abstract:
Like other tumors, aggressive soft tissue sarcomas (STS) use glycolysis rather than mitochondrial oxidative phosphorylation (OXPHOS) for growth. Given the importance of the cofactor coenzyme A (CoA) in energy metabolism, we investigated the impact of Vnn1 pantetheinase-an enzyme that degrades pantetheine into pantothenate (vitamin B5, the CoA biosynthetic precursor) and cysyteamine-on tumor growth. Using two models, we show that Vnn1+ STS remain differentiated and grow slowly, and that in patients a detectable level of VNN1 expression in STS is associated with an improved prognosis. Increasing pantetheinase activity in aggressive tumors limits their growth. Using combined approaches, we demonstrate that Vnn1 permits restoration of CoA pools, thereby maintaining OXPHOS. The simultaneous production of cysteamine limits glycolysis and release of lactate, resulting in a partial inhibition of STS growth in vitro and in vivo. We propose that the Warburg effect observed in aggressive STS is reversed by induction of Vnn1 pantetheinase and the rewiring of cellular energy metabolism by its products.
Insights
Vnn1 pantetheinase enzyme activity limits aggressive soft tissue sarcoma (STS) growth by restoring oxidative phosphorylation (OXPHOS) and limiting glycolysis. Higher VNN1 expression in STS patients correlates with improved prognosis, suggesting therapeutic potential.
Area of Science:
- Biochemistry
- Oncology
- Metabolic pathways
Background:
- Aggressive soft tissue sarcomas (STS) exhibit altered energy metabolism, relying on glycolysis (Warburg effect) over mitochondrial oxidative phosphorylation (OXPHOS).
- Coenzyme A (CoA) is crucial for energy metabolism, and its availability can influence tumor growth.
- Vnn1 pantetheinase degrades pantetheine into pantothenate (vitamin B5) and cysteamine, impacting CoA biosynthesis and potentially cellular metabolism.
Purpose of the Study:
- To investigate the role of Vnn1 pantetheinase in the growth and metabolism of soft tissue sarcomas (STS).
- To determine the impact of Vnn1 activity on tumor differentiation, growth rate, and patient prognosis.
- To elucidate the mechanisms by which Vnn1 influences cellular energy metabolism in STS.
Main Methods:
- Utilized two STS models to study Vnn1 function.
- Analyzed VNN1 expression levels in patient STS samples.
- Employed combined biochemical and cellular approaches to assess metabolic changes.
- Measured CoA pools, OXPHOS, glycolysis, and lactate production.
Main Results:
- Vnn1-positive (Vnn1+) STS exhibited slower growth and remained differentiated.
- Detectable VNN1 expression in patient STS was associated with an improved prognosis.
- Vnn1 activity restored CoA pools, supporting OXPHOS.
- Cysteamine production by Vnn1 limited glycolysis and lactate release, inhibiting STS growth in vitro and in vivo.
Conclusions:
- Vnn1 pantetheinase can limit aggressive STS growth by reversing the Warburg effect.
- Restoration of CoA pools and maintenance of OXPHOS are key mechanisms.
- Vnn1-induced metabolic rewiring, including cysteamine production, contributes to tumor growth inhibition.
- Vnn1 represents a potential therapeutic target for soft tissue sarcomas.
Related Concept Videos
Limiting Reactant
Animal Mitochondrial Genetics
The Number e as a Limit
Population Growth
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Export of Mitochondrial and Chloroplast Genes

